WHO Reaches Tentative Agreement on Pandemic Prevention Framework
4/12/2025 5:12:18 PM
"We have an accord in principle" and the final version will have to be okayed by the various member states, Anne-Claire Amprou, who is also French ambassador for world health, said.
Amprou said delegates would meet on Tuesday in Geneva to put the finishing touches to a landmark text on pandemic prevention, preparedness and response and give it their definitive seal of agreement.
The text will then require the final seal of approval from all World Health Organization members at the World Health Assembly in Geneva at the end of May.
The approval came after a marathon discussion session stretching for almost 24 hours after which delegates broke into enthusiastic applause lasting several minutes.
"This is a very good signal. You are part of an incredible history in the making," said WHO director-general, Tedros Adhanom Ghebreyesus.
"This is a good gift to our children and our grandchildren," said Tedros, who remained ensconced with delegates throughout the night as they thrashed out an agreement.
Several sources told AFP one of the main sticking points as delegates inched their way towards an accord was paragraph 11 of a text extending to some 30 pages on defining technology transfer for production of health products related to pandemics, particularly to benefit developing countries.
Latin American countries are also pushing for facilitation of the transfer.
The issue had been a bone of contention in poorer countries during the Covid-19 pandemic as they saw rich nations hoard vaccine doses and other tests.
Several countries where the pharmaceutical industry is a major economic player oppose the idea of mandatory transfers and have insisted on it being voluntary.
Amprou said delegates would meet on Tuesday in Geneva to put the finishing touches to a landmark text on pandemic prevention, preparedness and response and give it their definitive seal of agreement.
The text will then require the final seal of approval from all World Health Organization members at the World Health Assembly in Geneva at the end of May.
The approval came after a marathon discussion session stretching for almost 24 hours after which delegates broke into enthusiastic applause lasting several minutes.
"This is a very good signal. You are part of an incredible history in the making," said WHO director-general, Tedros Adhanom Ghebreyesus.
"This is a good gift to our children and our grandchildren," said Tedros, who remained ensconced with delegates throughout the night as they thrashed out an agreement.
Several sources told AFP one of the main sticking points as delegates inched their way towards an accord was paragraph 11 of a text extending to some 30 pages on defining technology transfer for production of health products related to pandemics, particularly to benefit developing countries.
Latin American countries are also pushing for facilitation of the transfer.
The issue had been a bone of contention in poorer countries during the Covid-19 pandemic as they saw rich nations hoard vaccine doses and other tests.
Several countries where the pharmaceutical industry is a major economic player oppose the idea of mandatory transfers and have insisted on it being voluntary.